8-47935841-G-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006904.7(PRKDC):​c.1338C>A​(p.Phe446Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000421 in 1,613,922 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F446Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 2 hom. )

Consequence

PRKDC
NM_006904.7 missense

Scores

4
9
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.76

Publications

1 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011797667).
BP6
Variant 8-47935841-G-T is Benign according to our data. Variant chr8-47935841-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475218.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006904.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKDC
NM_006904.7
MANE Select
c.1338C>Ap.Phe446Leu
missense
Exon 13 of 86NP_008835.5
PRKDC
NM_001081640.2
c.1338C>Ap.Phe446Leu
missense
Exon 13 of 85NP_001075109.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKDC
ENST00000314191.7
TSL:1 MANE Select
c.1338C>Ap.Phe446Leu
missense
Exon 13 of 86ENSP00000313420.3
PRKDC
ENST00000338368.7
TSL:1
c.1338C>Ap.Phe446Leu
missense
Exon 13 of 85ENSP00000345182.4
PRKDC
ENST00000697591.1
n.1379C>A
non_coding_transcript_exon
Exon 13 of 15

Frequencies

GnomAD3 genomes
AF:
0.00240
AC:
365
AN:
152150
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00849
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000691
AC:
172
AN:
249048
AF XY:
0.000496
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000214
AC:
313
AN:
1461654
Hom.:
2
Cov.:
31
AF XY:
0.000193
AC XY:
140
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.00815
AC:
273
AN:
33480
American (AMR)
AF:
0.000179
AC:
8
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1111834
Other (OTH)
AF:
0.000331
AC:
20
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00240
AC:
366
AN:
152268
Hom.:
2
Cov.:
32
AF XY:
0.00226
AC XY:
168
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00849
AC:
353
AN:
41560
American (AMR)
AF:
0.000654
AC:
10
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000733
Hom.:
0
Bravo
AF:
0.00279
ESP6500AA
AF:
0.00964
AC:
38
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.000877
AC:
106
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Aug 07, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Benign
-0.049
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.47
T
PhyloP100
1.8
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-4.4
D
REVEL
Uncertain
0.52
Sift
Uncertain
0.0060
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.85
MutPred
0.56
Gain of loop (P = 0.1069)
MVP
0.84
MPC
0.70
ClinPred
0.046
T
GERP RS
2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.53
gMVP
0.67
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61729514; hg19: chr8-48848401; API